Introduction
Quality face-to-face communication between health care workers and their patients/clients is the most important medical procedure, as it leads to information transfer that affects patient's compliance, adherence, clinical outcomes and general client satisfaction [1] . There has been an extensive debate regarding when and how to disclose genetic data to research participants in studies with a genetic component; consequently, researchers and research ethics committees continue to struggle with the questions on whether research protocols should adopt provisions about the return of genetic data and if so, how this should take shape [2] .
Sandy Oliver and team [3] argue that, it is evident that, a clear process on how to relay results to a research participant has not been established. Some researchers relay results through a phone call, some research participants receive their results directly from the laboratory with no explanations and others are given their results by the researchers in the clinical area. This is without considering privacy and psychological needs of the participant [3] . A study done by Hall et al. [4] clearly illustrated one of the main dilemmas inherent in disclosing carrier status, involving the issue of confidentiality. The debate emphasize on the issue of whom the information belongs, that is, the fact that the results should be disclosed to either the mother, father, the couple or the entire family. To address ethical issues and patient comfort, Baille and others [5] elaborated a six-step protocol, to follow during disclosure of bad news. These are;
1. Setting up the interview that is arranging for privacy, involving the relatives and managing time constraints and interruptions. 2. Assessing, the patient/relatives perception. 3. Obtaining the patients perception that is, ensuring that the patient/relative understands well 4. Giving knowledge and information to the patient/relative. 5. Addressing the patient's emotions with empathic response 6. Strategy and summary.
The amount of information that should be given to research participants with genetic disorders is still under debate. It is not clear whether the information given to them currently is adequate or not. If researchers have life-saving genetic information of immediate clinical utility about a research participant, then a strong case in disclosing these results is made, grounded in the principle of beneficence, that is doing well for the sake of others [6] . He further argued that participants in studies are likely to learn that they are heterozygous carriers of more than one serious autosomal recessive disease, yet they do not know the reasons for refraining from having children. Adequate disclosure counseling, must consider the risk of stigmatization that carrier status represents, and this is based especially on cultural and social issues where heterozygous individuals are considered lesser persons in the society [2] . Bredenoord and team [2] , further argues that disclosure should emphasize on emotional and psychological needs of Sicklers, and include -marital counseling before marriage of Sicklers, explaining pain episodes experienced in the course of their lifetime and priapism episodes experienced by male patients.
Vreeman, et al [7] argued that potential risks of disclosure for example fear, could negatively impact children and family psychological health, resulting in depression. Potential risks of disclosure have not been studied extensively in research limited resource setting. Since HIV is a lifetime disease just like sickle cell disease, disclosure has similar impact in both cases. It was thus important to carry out this study in order to determine the perception on the adequacy of disclosure process by parents/guardians of sickle cell research participants attending Hemato Oncology Clinic.
Dilemmas arise when a person's health care needs are not consistent with values held by others in society, persons with a genetic condition may prefer not to learn that their offspring is at risk for the condition. This presents an ethical dilemma for the clinician or researcher who must balance respect for the persons' wishes with his/her need to ensure that the couple and the client receive appropriate care [8] . There is no ethical justification for withholding test results. The fact that information maybe disturbing not just to the research participant, but also to the health care provider who has to convey it has not been proved. Most health care providers evade disclosure leaving a client with psychological torture [9] .
Confidentiality as an ethical issue should be maintained at all cost during the disclosure process. The area used for disclosure should be private and conducive to the research participant during disclosure. It is an ethical responsibility to maintain participants' confidentiality. Several organizations have addressed the challenges of maintaining confidentiality in the genetic counseling setting [10] .
In a study done on consulting communities on feedback of genetic findings in international health research, sharing sickle cell disease and carriers' information in Coastal Kenya, results indicated that perceived social and health benefits generated strong support for disclosing findings on the disease. However, the balance of social benefits and harms was less clear for sickle cell trait [11] . Despite extensive debate on disclosing genetic results, there is no consensus regarding when and how to disclose individual results to research participants with genetic components. Once there is genetic disorder discovery, the question then arises as to who and how to counsel the patient and/or family [12] . Therefore, it was necessary to assess the process of disclosure of sickle cell results to parents/guardians of research participants attending Hemato-oncology Clinic. Consequently, this study sought to find out ethical shortcomings in the disclosure process experienced by parents/guardians of sickle cell research participants attending the Hemato-Oncology Clinic of a teaching hospital in Kenya.
Broad Objective
To assess the process of disclosure to parents/guardians of children with sickle-cell disease enrolled in the sickle-cell study at AMPATH Hemato-oncology clinic 1.2 Specific Objectives 1. To identify the process of disclosure of sickle cell results to parents/guardians of children with sickle-cell disease enrolled in the sickle-cell study at the Hemato-oncology Institute. 2. To determine the perception on the adequacy of disclosure process by parents/guardians of children with sickle-cell disease enrolled in the sickle-cell study at the Hemato-oncology Institute. 3. To determine the ethical considerations in the disclosure process for parents/guardians of children with sickle-cell disease enrolled in the sickle-cell study at the Hemato-oncology Institute
II. Methodology
A. Design A qualitative descriptive cross sectional study design was used to meet the objectives of this study. Key informant interviews and in-depth interviews were carried out using semi-structured questionnaires, with responses to interviews recorded verbatim.
B. Setting
The present study was carried out at a Hemato-oncology clinic in a teaching hospital located in Eldoret town, in Uasin Gishu County, Kenya. The hemato-oncology clinic has a sickle-cell clinic as one of the clinics that deals specifically with sickle cell patients from diagnosis, treatment and follow-up services. The clinic also serves as a center for research and among ongoing research is a clinical trial of hydroxyl-urea drug on sickle cell disease among children. The study currently has 62 enrolled research participants that formed part of the study participants.
C. Sampling procedure
Convenient sampling was used to identify parents/guardians for study based on their clinic appointments over a period of three months. While purposive sampling technique was employed to identify key informants (research staff) based on their direct involvement in the sickle-cell study at the hemato-oncology clinic. The (5) healthcare providers and the (62) parents/guardians of children having sickle cell disease enrolled in the sickle cell study participated in the current study. All patients enrolled for sickle cell care were below 18 years of age.
D. Data analysis
Data was transcribed, translated and analyzed using NVIVO software into themes and narratives that were then discussed in relation to past studies.
E. Ethical considerations
A formal approval on the study procedures was sought from the institutional research and ethics committee (IREC), and permission to carry out the study was obtained from the hospital administration and Hematooncology department prior to data collections.
III. Results

III. 1 Socio-demographic data
Descriptive results (Table 1) showed that majority of the parents/guardians of patients with sickle cell disease were females 37(80%) while minority were males 9(20%). The results indicate that females played a bigger role in taking care of the sick patients while attending the Hemato-oncology clinic. Most parents/guardians were found to be relatively young, with 41% and 35% aged between 30 and 40 years and less than 30 years, respectively. Only 24% of them were over 40 years. The results (Table 1) showed that most patients were accompanied to the hospital by their parents (n=40, 87%) compared with guardians (n=6, 13%). The results implied that most of the children in the study had living parents. The number of individuals in each household ranged from a minimum of two to a maximum of 14, with a mean of 5.12 and a SD of + 2. . Majority of the parents/guardians had college/university level of education 21 (46%), followed by those who had elementary/primary education 14(30%). Those with secondary level of education comprised only 24% (n=11). Most of the parents/guardians attending the Hemato-oncology clinics used public means of transport 40 (87%) while only minority used private means 6(13%).
Most parents/guardians of patients diagnosed with sickle cell disease took about an hour to reach the health care facility, with a range of 10-300 minutes (5hrs) and mean time of 70 minutes.
Most parents/guardians of patients diagnosed with sickle cell disease are in formal employment 17 (37%), followed by those who are self-employed 16 (35%) and those that are unemployed 13 (28% 
III. 2.2 Communication Process
When the respondents were asked how results of sickle cell disease were communicated to them; the study found that results on sickle cell disease was communicated to them mainly by oral means (n=43), in which health care providers explained to parents and guardians on a one on one interaction. Only a paltry of the parents/guardians, one parent (n=1) and two parents/guardians (n=2) were told of the sickle cell condition through telephone or by mail means, respectively. For instance, one guardian participant (27) 
.When they did a confirmatory test here, it is the doctor who gave us the results "
The study found that nurses could be conveying sickle cell disease information to clients because doctors might not be readily accessible. For example, one health care provider (01) reported that; "The nurses……………Many at time I relay information to clients since they come through me before they go to the doctor, if the patient also comes to the clinic on a day that is not a clinic day, I relay the information since the doctor is unavailable".
III.3 Expectation on the results
Eight out of every 10 respondents, i.e. parents/guardian (n = 38) answered that the sickle cell results they received were at variance with their expectations. Only two out every 10 participant expected the results that they received. One parent/participant (14), who did not expect the child to have sickle cell anemia, reported; Actually, I did not expect she could have sickle cell because, there is no history in our family, so it was a shock to me but with time, I accepted. There were parents who were not surprised by the results they received, this is because their older children had the same condition. For instance, one participant /parent (22) 
stated that: ''I knew about it, so I was not that shocked because my first born died of sickle cell"
Others expected the worst because the child had a history of recurrent illnesses. One guardian participant (42) explained: "Me I was expecting anything because he has disturbed me since January" III. 4 Perceptions of Health Care providers on the Disclosure Process One of the health care providers (03) reported that, for a client to be enrolled to the study, a confirmatory test has to be done. If positive, then disclosure process began from here. During the initial encounter with the client, a little information on sickle cell is given then; information is delivered in portions throughout the entire study. 
III.5.1 Information Parents want to know during disclosure
The study found that respondents wanted to know various aspects of sickle cell disease during the disclosure process. Such information included the existence of discrepancy in results, the best nutrition for sickle cell patients, relationship between fever and sickle cell, and the lifespan of the one suffering from sickle cell. Others included whether somebody should disclose sickle cell condition when dating, if a sickle cell patient could get children, how the disease can be prevented, whether family members can be carriers, whether sickle cell is curable, and how one can manage the condition in order to live long. For instance, a parent participant (35) 
He had a lot of patients; it was after noon at two o'clock people were many who were given appointment that day so he taught us little"
Most participants (n=30) noted that they were not given enough information on how the child will be managed, and clinicians felt they did not spent enough time with the participants. One parent participant (26) reported that; "No, I just followed the instructions from the doctor". Health care professional (03) also reported that: "I think the other challenge is that when you are working in the clinic you have a queue of patients probably you never spend enough time explaining the diagnosis so I think that's where the genetic counselor should come in handy as they will have entire day doing disclosure unlike a clinician who has other responsibilities" III.5.3 Feelings after disclosure The study found that parents and guardians experienced varied emotions upon learning of the presence of sickle cell anemia in their children. The feelings included being bored, bitter, normal, devastated, angry, surprised, sad, helpless, annoyed, painful, and feeling nothing. Several participants had this to say; Surprised: Some participants were surprised to hear that one of their siblings was a sickler. A parent Participant (22) 
... I have never imagined this, the way my two other siblings died with the same symptoms yet in my health centre was always told that it is malaria…… Please come and educate our people because most of my relatives have been dying with the same problem and we are told it is malaria. We have even imagined it could be witchcraft following us as a family…….." Normal: a parent participant (1) reported that, "Aaah….. I just said it is okey! It is normal in Nyanza eeh…. I the mother is a Luo, and there it is common, so me I understood, but her father felt bitter since he is a Luhya, I was like it has happened"
Depression: A parent participant (19) 
III.6 Ethics of the Disclosure Process
The study investigated a triad of major ethical issues: confidentiality, consenting, and whether justice was observed. These findings were bolstered by face-to-face interviews. One parent participant (43) 
III.7 Summary of results
The general objective of this study was to assess the process of disclosure given to parents/guardians of children with sickle-cell disease enrolled in the sickle-cell study at a Hemato-oncology clinic in a teaching hospital in Kenya. Specifically, the study aimed to identify the process in disclosure, determine the perception of the adequacy of the process and determine the ethical considerations in the disclosure process.
The study found that results on sickle cell disease was communicated to participants mainly by oral means (n=43, 94%), in which health care providers explained to parents and guardians on one-on-one interaction. Only a paltry 2% (n = 1) and 4% (n=2) of the parents were told of the sickle cell condition through telephony or by written means, respectively. Parents who received written communication on sickle cell condition were likely to be college/university educated whereas those who were told results orally were likely to be female, have elementary or secondary education, and be either unemployed or self-employed. Doctors are the main people (87%, n = 40) who convey sickle cell disease information to the parents, with only 13% (n = 6) communicated to by nurses. Generally, most participants (n = 43, 93%) found out about sickle cell anemia through hospital tests after several admissions following the ailment of their children. Eight out of every 10 respondents did not expect that their children would be diagnosed with sickle cell whereas the rest expected the results.
The study showed that more respondents (n = 26, 57%) felt that the information they received was not adequate. compared to those who thought that it was (n = 20, 44%).The perception about the adequacy of information received was not significantly associated with any biographical category, that is, regardless of the respondents' gender, age, education, and occupation, more of them always felt that the information provided during the disclosure process was not enough. An overwhelming proportion of respondents (n=38, 83%) felt that the time used in the disclosure process was not adequate compared to those who thought that it was (n=8, 17%).Young, self-employed female mothers, with both college and elementary education, are likely to consider the time given for the disclosure process as being inadequate while older participants were likely to find the time used as being adequate. Parents experienced varied emotions upon learning of the presence of sickle cell anemia in their children such as being devastated, disturbed, angry, depressed, surprised, and normal.
The study showed that most participants (n=31, 67%) felt that confidentiality was maintained relative to those who answered that it was not (n=15, 33%). In addition, six out of every ten respondents (61%) felt that justice was observed during the consenting process. However, majority of the participants were of the opinion that the consenting process was not proper (n=27, 59%) compared to those who felt that it was (n=19, 41%). Participants who felt that confidentiality was not maintained during disclosure were likely to be well educated (college or university), employed and middle aged parents.
IV. Discussion
The study found out that, results on sickle cell disease were communicated to parents and guardians mainly by oral means in one-on-one interaction with only a few parents being informed through telephony or written means. The results indicated that females played a bigger role in taking care of the sick patients while attending the clinic. This supports a study done in South Africa in regard to family role in taking care of the sick, which showed that females play a major role [13] . Baille and others [5] came up with a six-step strategy for delivering bad news, in order to support the patient and enable an appropriate future strategy for managing the condition. These included setting up the interview (by arranging for privacy and making connection with the patient), assessing the perceptions of the client, obtaining the patients/relatives/parents invitation, done by giving the parents the opportunity to know what they desire to know, and providing knowledge and information to the patient. Others were, addressing the patient's emotions with empathic responses done by connecting the emotions with reason by making a connection statement and lastly, discussing with patient/relative if they are ready for the discussion and giving them a way forward. The fact that most parents are given information in a one on one-interaction with medical practitioners suggested that some steps in the procedure, for instance, interviews and discussion with patients, are followed [5] . However, it is doubtful that the whole elaborate process is followed. This was because the process was hurried, as some participants reported that the doctor just came with the results and said that it was positive, without any preparation. Thus, this study, like Sandy Oliver et al. [3] , reports that health care practitioners may not be following the full disclosure process, because of the pressure of time or busy schedules, such that their clients might not be obtaining complete information or emotional support in case of positive diagnosis. According to Henley and colleagues, the quality of face-to-face communication between health care workers and patient/client is the most important medical procedure, as it leads to information transfer that affects patient's compliance, adherence, clinical outcomes and general client satisfaction [14] . It therefore follows that if these sessions are turned into merely "one-minute encounters", in which the health practitioner essentially reads out the results of the sickle cell condition, they might not be achieving their intended aim -which is to disclose all necessary information in an emotionally supportive environment. It was satisfactory that the oncology clinic used only a few instances in which the respondents were communicated to by either written means or telephony. However, the fact that these relatively impersonal means were used at all suggested that personal connection between the discloser and the client might not have been achieved. The study found out that doctors were the main people who conveyed sickle cell disease information to the parents. However, in some cases, nurses also passed the information to clients. Traditionally, the duty of transmitting medical information to patients has rested with doctors, however, nowadays, nurses and other medical practitioners have played an increasing role [15] .Edwards and team [15] , investigated parents' perception of how health professionals communicated in an interview of 20 mothers and 17 fathers whose babies were one-week old in neonatal unit. They reported that parents felt that nurses communicated better than doctors did. Nurses were found to be more effective when they changed their behavior or conversation to meet the needs of parents. Norgaard et al [16] found that parents believed that doctors did an excellent job in providing them with information about their sick children. The latter study [16] also reported that nurses spent the most time with parents, explained their child's condition to them and were their principal source of information. Thus, it appears that who presents information -doctors or nurses -might not be important. What is pertinent is that the information must be accurate and detailed and be delivered by a person with a pleasant, attentive and caring attitude. The study findings thus found out that a collaborative team is vital in disclosure. On adequacy of information, more respondents felt that they were given inadequate information and this was reported by every category of biographical variable. This concurs with a study done by Bredenoord and others [2] , where it was argued that the amount of information given to research participants with genetic disorders is still under debate. However, it is generally accepted that if researchers have life-saving genetic information of immediate clinical utility about a research participant, then a strong case can be made disclosing these results grounded in the principle of beneficence, which is doing well for the sake of others [2] . Parents for instance wanted to know about the best nutrition for sickle cell patients, relationship between fever and sickle cell, and the lifespan of the one suffering from sickle cell. Others included whether somebody should disclose sickle cell condition when dating, could a sickle cell patient get children, how can the disease be prevented, can family members be carriers, is it curable, and how can one manage the condition in order to live long. The study found that this information was inadequately delivered at the clinic. In a study conducted in the coastal region of Kenya [11] , showed that perceived health and social benefits generated strong support for disclosing results on sickle cell disease. It is therefore crucial for adequate information to be given to parents in order to redeem these benefits. This is especially so to parents who were ignorant of the disease. The chief reason for the paucity of information appears to be lack of time, with participants feeling that doctors had too many patients, which reduced the time medical officers could dedicate to an individual parent in explaining sickle cell results. This conclusion is supported by the fact that the study found an overwhelming proportion of respondents who felt that the time used in the disclosure process was not adequate. Clinicians themselves felt they did not spent enough time with the participants. This could be detrimental because the study showed that even parents with no or modest education were given only bits of information [17] .The study reported that disclosure of results came with burdens, for instance, considerable time preparation are required if results are to be comprehensively disclosed to lay audience. It might be helpful that if doctors are too busy because they are fewer, experienced and knowledgeable nurses and other medical officers could be drafted to help in disclosure. The study found that there were frequent changes in doctors, with the one carrying out the initial test often different from the one conveying the results. Consequently, a longer lasting, potentially trustful, and emotionally supportive relationship between a parent and a doctor, as espoused by Graves et al. [18] , was never established. It may therefore not be surprising that the parents in this study experienced harrowing emotions upon learning of the presence of sickle cell anemia in their children such as being devastated, disturbed, and depressed. Oliver and team [3] suggested that in spite of counseling, receiving an initial screen positive result for sickle cell disease can be difficult to understand and leads to anxiety, confusion and depression. It is true that receiving harrowing information about a life-long genetic disorder will be a cruel blow to anyone. However, the blow will be lessened by counseling as it happens with HIV -AIDS disclosures [19] . Indeed, medical practitioners in the hemato-oncology hydroxyl urea study advised that psychological counselors should be involved in the disclosure process.
Regarding ethical issues, the study showed that most participants felt that confidentiality was maintained during disclosure. Sickle cell, just like HIV -AIDS is a lifetime disease, and hence the ethical question of who should be given information is pertinent. In a sickle cell study [20] raised the question of to whom the information belongs: the child, the mother or the couple. Generally, physicians only have duties to their patients (in this case, the children), and, unless a patient expressly consents to disclosure or a law requires it, they are obliged to hold patients' medical information in the strictest confidence [21] . Given that the clients in this study were children, the hemato-oncology Clinic is right to disclose the information to their parents. However, the issues reported by this study, for instance, publicly telling parents that their children have sickle cell or not enclosing the test results in an envelope might be ill advised. The fact that participants who felt that confidentiality was not maintained during disclosure were likely to be well educated (college or university), employed and middle aged parents, suggested that they were the ones who were discerning enough to the fact.
In addition, six out of every ten respondents felt that justice was observed during the consenting process. However, majority of the participants were of the opinion that the consenting process was not proper. Other researchers [19, 22] have noted that deficiency of informed consent continues to be ignored and its practice remains an issue of concern.
V. Conclusion
The present study identified that the WHO six step protocol is not adhered to during disclosure of genetic disorders to patients and relatives in health care institutions. Most respondents further felt that inadequate information on genetic disorders was made available to them mainly due to limited time that healthcare providers are willing to spend on the disclosure process.
VI. Recommendations
In the light of the main study finding, the following recommendations are proposed.  The six-steps protocol in the disclosure process should be integrated in the standards operating procedures genetic disorders disclosure as each of the stage has a pertinent function.  Health care providers should convey adequate information about genetic disorders to their clients and strive to project a caring, understanding and pleasant attitude.  Health care institutions should allow a collaborative team of doctors, nurses, genetic and psychological counselors to participate in disclosure.  Psychological counselors should be incorporated in the clinic to offer continuous counseling on lifelong genetic disorders since they can be traumatizing to the client.  Health care institutions should set aside disclosure rooms to strengthen confidentiality between practitioner and patient. 
